← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 31, 2014Last known activity
Sep 30, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03944876CollaboratorPhase 3Sep 30, 2019
- NCT02365155Study directorN/AOct 31, 2014
- NCT02365155OfficialN/AOct 31, 2014
Details
- Last known activity
- Sep 30, 2019